This Personalized Crispr Therapy Is Designed to Attack Tumors
In a small study, researchers modified patients’ immune cells to target their particular cancer—but it only worked for a third of volunteers.
This Gulp of Engineered Bacteria Is Meant to Treat Disease
A small study of people with a rare disorder that prevents them from processing protein is an early attempt at creating “living” medicines.
Could Crispr Flip the Switch on Insecticide Resistance?
Many insects, like the mosquitoes that spread malaria, have evolved a tolerance to chemical sprays. What if we could reboot their genes?